Clopidogrel Monotherapy Significantly Reduced MACE vs Aspirin Monotherapy Post-PCI: SMART-CHOICE 3
Key Points: Standard cardiology practice recommends aspirin monotherapy indefinitely after DAPT for prevention of cardiovascular… Continue Reading
Featured NewsView All
Key Points: Standard cardiology practice recommends aspirin monotherapy indefinitely after DAPT for prevention of cardiovascular… Continue Reading
Key Points: The FAME 3 trial tested whether percutaneous coronary intervention (PCI) could offer comparable… Continue Reading
Key Points: This study presents updated national data from the Race Associated Cardiac Event Registry… Continue Reading
Featured PodcastsView All
Dr. Fanikos Speaks at Brigham and Womens’ Hospital
Podcast: Download
NewsView All
Key Points: Prior trials have demonstrated limited benefit to intra-aortic balloon pump (IABP) use in… Continue Reading
Key Points: While fluid restriction is a standard recommendation for patients with chronic heart failure… Continue Reading
Key Takeaways: Elevated baseline NT-proBNP and hs-cTnT levels were associated with higher cardiovascular event rates,… Continue Reading
Key Takeaways: Intramyocardial autologous bone marrow cell therapy was safe in patients with ischemic HFrEF… Continue Reading
Key Takeaways: SHR-1918, an ANGPTL3 inhibitor, significantly reduced LDL cholesterol by approximately 22–30% and triglycerides… Continue Reading
Key Takeaways: A deep learning ECG model significantly outperforms clinician interpretation in rapidly identifying patients… Continue Reading